Immunovant, Inc. · NASDAQ:IMVT
Venker Eric sold 3,092 Immunovant, Inc. shares (Form 4)
Traded Jul 1 to Jul 2, 2026 · Filed Jul 6, 2026
From Jul 1 to Jul 2, 2026, Venker Eric (Director, Chief Executive Officer) sold 3,092 Immunovant, Inc. shares at US$38.48 for US$119K, leaving 254,280 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 3,092 shares
- Price
- US$38.48
- Value
- US$119K
- Holding after
- 254,280 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 92,188 | US$14.46 | 344,001 | Direct |
| Jul 1, 2026 | Common Stock | Disposition | 86,629 | US$38.14 | 257,372 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 3,092 | US$38.48 | 254,280 | Direct |
Source
Related
- Immunovant, Inc.
- Venker Eric
- Immunovant, Inc. shareholders
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Venker Eric · Apr 9, 2026
- Form 4 · Venker Eric · Apr 3, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Pande Atul · Aug 28, 2026